ITGAX and neoplasm: Based on the reduced expression of APC activation markers such as MHCII, CD11c, and CD83 on CD11b+ cells, we analyzed tumors for changes in the number of tumor-associated CD8 T cells and observed a decrease in TILs in CHRNA7KO mice compared with WT mice (Fig. 4G).